Anti-glomerular basement membrane disease].

Anti-glomerular basement membrane disease is a rare disease. In its classical presentation it associates rapidly progressive glomerulonephritis and diffuse alveolar hemorrhage, linked to the presence of antibodies targeting type IV collagen in the glomerular and alveolar basal membrane. Anti-GBM disease warrants prompt medical management to limit permanent kidney damage and mortality. Treatment includes plasma exchanges to quickly remove pathogenic antibodies and immunosuppressants to stop their production. This article reviews the pathogenesis and current treatments.

Citation

Mathias Stevanin, Sébastien Kissling, Cécile Daccord, Samuel Rotman, Denis Comte, Camillo Ribi. Anti-glomerular basement membrane disease]. Revue medicale suisse. 2023 Apr 05;19(821):680-685

Mesh Tags

Substances

PMID: 37017350

search → result